| 15256420 |
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518
Gilliland, DG,
Lokker, NA,
Curley, DP,
Clark, JJ,
Giese, NA,
Yu, JC,
Cools, J
|
Blood |
2004 |
| 12124172 |
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
Gilliland, DG,
Boulton, CL,
Kelly, LM,
Duclos, N,
Scarborough, RM,
Li, J,
Neuberg, D,
Amaral, SM,
Sullivan, CM,
Hollenbach, S,
Pandey, A,
Lokker, NA,
Williams, I,
Apatira, M,
Abe, K,
Curley, DP,
Giese, NA,
Yu, JC
|
Cancer Cell |
2002 |
| 22354205 |
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
Pearson, AD,
Avery, S,
Workman, P,
Faisal, A,
Mair, D,
Atrash, B,
Blagg, J,
Bavetsias, V,
Linardopoulos, S,
Mirabella, F,
Valenti, M,
Eccles, SA,
Moore, AS,
de Haven Brandon, A,
Sun, C,
Swansbury, J,
Gonzalez de Castro, D,
Raynaud, FI
|
Leukemia |
2012 |
| 27132990 |
Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation
Huang, A,
Liu, K,
Wen, S,
Huang, P,
Liu, D,
Hu, Y,
Garcia-Manero, G,
Ju, HQ,
Zhan, G
|
Cancer Lett. |
2016 |
